Business Description
Eton Pharmaceuticals is a US-based company founded in 2017 and headquartered in Deer Park, Illinois, that specializes in treatments for rare and often underserved medical conditions. The company currently sells eight approved products targeting disorders such as Wilson disease, adrenal insufficiency, and several metabolic conditions. Eton also has a pipeline of five additional treatments in advanced development, covering conditions including neonatal diabetes and adrenal crisis.
